Although pathogenic variants in FBN1 are associated with an increased risk for dilated cardiomyopathy in both patients and mice, FBN1 is expressed in many tissues, including SMCs, cardiomyocytes, and cardiac fibroblasts [23]. This evidence concerns the gene FBN1 and dilated cardiomyopathy.